Abstract Title:

Statins accelerate the onset of collagen type II-induced arthritis in mice.

Abstract Source:

Arthritis Res Ther. 2012 Apr 26 ;14(2):R90. Epub 2012 Apr 26. PMID: 22537858

Abstract Author(s):

Rob J Vandebriel, Hilda Ji de Jong, Eric R Gremmer, Olaf H Klungel, Jan-Willem Cohen Tervaert, Wout Slob, Jan Willem van der Laan, Henk van Loveren


ABSTRACT: INTRODUCTION: Statins (hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors) are effective in reducing the risk of cardiovascular morbidity and mortality in patients with hyperlipidemia, hypertension, or type II diabetes. Next to their cholesterol lowering activity, statins have immunomodulatory properties. Based on these properties, we hypothesized that statin use may eventually lead to dysregulation of immune responses, possibly resulting in autoimmunity. We have recently shown in an observational study that statin use was associated with an increased risk of developing rheumatoid arthritis. Our objective was to investigate whether a causal relationship could be established for this finding. METHODS: The mouse collagen type II (CII)-induced arthritis (CIA) model was used, with immunization, challenge, and euthanasia at days 0, 21, and 42, respectively. Statins were given orally before (day -28 until day 21) or after CIA induction (day 21 until day 42). Atorvastatin (0.2 mg/day) or pravastatin (0.8 mg/day) was given. Arthritis was recorded 3 times a week. Serum anti-CII autoantibodies, and cytokines in supernatants from Concanavalin A-stimulated lymph node (LN) cells and CII-stimulated spleen cells were measured. RESULTS: Statin administration accelerated arthritis onset and resulted in 100% arthritic animals, whereas in the non-statin controls only 7 out of 12 animals developed arthritis. Atorvastatin administration after CIA induction resulted in earlier onset than atorvastatin administration before induction, or pravastatin administration before or after induction. The arthritic score of animals given pravastatin before CIA induction was similar to that of the non-statin controls, whereas the other groups that received statins showed higher arthritic scores. Atorvastatin administration, especially before CIA induction, increased anti-CII autoantibody production. Interleukin-2 (IL-2) and interleukin-17 (IL-17) production by LN and spleen cells was higher in CIA animals than in phosphate buffered saline (PBS) controls, but was not affected by statin administration. While interferon-gamma (IFN-*) production was not affected by CIA induction, atorvastatin administration before CIA induction increased the production of this cytokine. CONCLUSIONS: These data support previous results from our observational studies, indicating a role for statins in the induction of autoimmunity.

Study Type : Animal Study
Additional Links
Adverse Pharmacological Actions : Inflammatory : CK(312) : AC(92)

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.